thebobh blogspot.com
SysAdmins - Forever!
Saturday, July 5, 2008. Ambrisentan A New Drug For Pulmonary Arterial Hypertension. A New Drug for PAH Clinical Pharmacology of Ambrisentan. In June 2007, the FDA approved ambrisentan LETAIRIS for the once-daily treatment of PAH to improve exercise capacity and delay clinical worsening. Click image to zoom. Pharmacokinetic data indicate hepatic impairment is likely to prolong the elimination of ambrisentan. The drug is not recommended for patients with moderate to severe liver disease, and patie.
OVERVIEW
This web page thebobh.blogspot.com currently has a traffic ranking of zero (the lower the superior). We have explored fifteen pages inside the domain thebobh.blogspot.com and found one website referring to thebobh.blogspot.com.
Pages Crawled
15Links to this site
1THEBOBH.BLOGSPOT.COM RANKINGS
This web page thebobh.blogspot.com has seen a fluctuation levels of traffic within the past the year.
Date Range
1 week
1 month
3 months
This Year
Last Year
All time
Date Range
All time
This Year
Last Year
Date Range
All time
This Year
Last Year
Last Month
LINKS TO WEB SITE
Historical Opinions Reviews And Info
Latest technology proved an unexpected aid to unearthing the past when an Italian man decided to look at internet maps of his home. Computer programmer Luca Mori found the remains of an ancient Roman villa when he browsed Google Earth maps showing satellite images of his local area. His curiosity was sparked by unusual shading by his home in Sorbolo, Parma. Mr Mori decided to alert experts from the National Archaeological Museum in Parma about his find.
WHAT DOES THEBOBH.BLOGSPOT.COM LOOK LIKE?
THEBOBH.BLOGSPOT.COM HOST
Our parsers identified that a lone page on thebobh.blogspot.com took one hundred and seventy milliseconds to come up. We could not find a SSL certificate, so our crawlers consider thebobh.blogspot.com not secure.
Load time
0.17 secs
SSL
NOT SECURE
Internet Protocol
173.194.121.44
WEBSITE IMAGE
SERVER OS AND ENCODING
I found that this domain is operating the GSE server.PAGE TITLE
SysAdmins - Forever!DESCRIPTION
Saturday, July 5, 2008. Ambrisentan A New Drug For Pulmonary Arterial Hypertension. A New Drug for PAH Clinical Pharmacology of Ambrisentan. In June 2007, the FDA approved ambrisentan LETAIRIS for the once-daily treatment of PAH to improve exercise capacity and delay clinical worsening. Click image to zoom. Pharmacokinetic data indicate hepatic impairment is likely to prolong the elimination of ambrisentan. The drug is not recommended for patients with moderate to severe liver disease, and patie.CONTENT
This web page thebobh.blogspot.com states the following, "Saturday, July 5, 2008." We saw that the webpage said " Ambrisentan A New Drug For Pulmonary Arterial Hypertension." It also said " A New Drug for PAH Clinical Pharmacology of Ambrisentan. In June 2007, the FDA approved ambrisentan LETAIRIS for the once-daily treatment of PAH to improve exercise capacity and delay clinical worsening. Pharmacokinetic data indicate hepatic impairment is likely to prolong the elimination of ambrisentan. The drug is not recommended for patients with moderate to severe liver disease, and patie."SEEK SIMILAR DOMAINS
Alone in this crowded room
Getting lost in my own atmosphere.
HPS EnvironnementHPS ENVIRONNEMENT
Pour être informé du lancement de la nouvelle version de notre site,.